Gottlieb CD, Shang Z, and Linder ME; The cysteine-rich domain of the DHHC3 palmitoyltransferase is palmitoylated and contains tightly bound zinc. J. Biol. Chem. (2015) 290:29259-69.
Yeste-Velasco M, Linder ME, and Lu, Y-J; Protein S-palmitoylation and cancer. BBA Cancer Reviews (2015) 1856:107-120.
Lai J and Linder ME; Oligomerization of DHHC-S-acyltransferases. J. Biol. Chem. (2013) 288:22862-70.
Nishimura A and Linder ME; A novel prenyl,palmitoyl CaaX modification of Cdc42 regulates RhoGDI binding and signaling activity. Mol. Cell. Biol. (2013) 33:1417-29.
Jennings BC and Linder ME; DHHC protein S-acyltransferases use a similar ping-pong kinetic mechanism but display different acyl-CoA specificities. J. Biol. Chem. (2012) 287:7236-45.
Hang HC and Linder ME; Exploring protein lipidation with chemical biology. Chemical Reviews (2011) 111:6341-58.
Nadolski M and Linder ME; Molecular recognition of the palmitoylation substrate Vac8 by its palmitoyltransferase Pfa3. J. Biol. Chem. (2009) 284: 17720-30.
Jennings BC, Nadolski MJ, Ling Y, Baker M, Harrison ML, Deschenes RJ and Linder ME; 2-bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro. J. Lipid Research (2009) 50:233-42.